For instance, a study combining miR-221 with miR-29c was able to correctly identify ~85% of early-stage (TNM I–II) HCC cases, versus ~46% by AFP at the standard 20 ng/mL cutoff [59]. This evidence concerns the gene AFP and hepatocellular carcinoma.